Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Yoshio Ohara is active.

Publication


Featured researches published by Yoshio Ohara.


Tetrahedron Letters | 1993

A novel synthetic method of HMG-CoA reductase inhibitor NK-104 via a hydroboration-cross coupling sequence

Nobuhide Miyachi; Yoshinobu Yanagawa; Hiroshi Iwasaki; Yoshio Ohara; Tamejiro Hiyama

Abstract The regioselective hydroboration of ethyl ( 3R, 5S )-3,5-isopropylidenedioxy-6-heptynoate, followed by the cross-coupling reaction with an aryl halide, provides ethyl ( 3R, 5S, 6E )-7-aryl-3,5-isopropylidenedioxy-6-heptenoate, a precursor of a highly potent HMG-CoA reductase inhibitor NK-104.


Bioorganic & Medicinal Chemistry Letters | 1999

First systematic chiral syntheses of two pairs of enantiomers with 3,5-dihydroxyheptenoic acid chain, associated with a potent synthetic statin NK-104

Mikio Suzuki; Yoshinobu Yanagawa; Hiroshi Iwasaki; Hiroyasu Kanda; Kazufumi Yanagihara; Hiroo Matsumoto; Yoshio Ohara; Yukari Yazaki; Ryozo Sakoda

First systematic chiral syntheses of two pairs of enantiomers with 3,5-dihydroxyheptenoic acid chain, associated with a potent synthetic statin NK-104 are reported. A pair of syn diol isomers (NK-104 and its enantiomer) was obtained efficiently by diastereomeric resolution. The synthesis of a pair of anti diol isomers (3-epimer and 5-epimer) was accomplished effectively by the asymmetric aldol reaction followed by anti stereoselective reduction as key steps. Their purity determinations were effected by chiral HPLC analysis.


Tetrahedron Letters | 1991

Synthesis of corey lactone via highly stereoselective asymmetric Diels-Alder reaction

Katsuaki Miyaji; Yoshio Ohara; Yasuhiro Takahashi; Toshihiko Tsuruda; Kazutaka Arai

Abstract We have succeeded in a highly stereoselective asymmetric Diels-Alder reaction between a chiral acrylate 3a derived from commercially available D-pantolactone 2 and 5-benzyloxymethyl-cyclopentadiene 4 to give the adduct 5a in 94% d.e. and 79% yield for the synthesis of Corey lactone 1 .


Tetrahedron Letters | 1993

A new synthetic route of corey lactone having ω-side chain

Katsuaki Miyaji; Yoshio Ohara; Yuka Miyauchi; Toshihiko Tsuruda; Kazutaka Arai

Corey lactone having ω-side chain 1a is an important intermediate for syntheses of prostaglandins. Now we have succeeded in developing a new synthetic route of 1a from methylenecyclopentanone having ω-side chain 2a. The new synthetic route has two crucial steps as follows. 1) Hydroxymethyl unit introduction by using organozinc reagent. 2) Oxidation of diol to lactone by using N-oxoammonium salt in combination with sodium bromite.


Archive | 1996

Thiazolidine and oxazolidine indoles with hypoclycemic activity

Yoshio Ohara; Mikio Suzuki; Keisuke Ohdoi; Nobuhide Miyachi; Katsuhiro Kato; Tetsuya Kobayashi; Ken-ichi Shikada; Masaki Kitahara; Takeshi Naito; Takashi Yotsumoto; Chie Miyakoshi


Archive | 1992

Diastereomer salt of optically active quinolinemevalonic acid

Yoshio Ohara; Mikio Suzuki; Yoshinobu Yanagawa; Hiroshi Iwasaki; Nobuhide Miyachi


Bulletin of the Chemical Society of Japan | 1995

Synthesis of an Artificial HMG-CoA Reductase Inhibitor NK-104 via a Hydrosilylation–Cross-Coupling Reaction

Kyoko Takahashi; Tatsuya Minami; Yoshio Ohara; Tamejiro Hiyama


Archive | 1999

PROCESS FOR THE PREPARATION OF QUINOLINE DERIVATIVE AND INTERMEDIATE THEREFOR

Yoshio Ohara; Mikio Suzuki; Yoshinobu Yanagawa; Yasutaka Takada


Archive | 1993

Condensed pyridine type mevalonolactone intermediate and process for its production

Tamejiro Hiyama; Tatsuya Minami; Yoshinobu Yanagawa; Yoshio Ohara


Archive | 2002

Substituted benzopyran derivatives against arrhythmia

Yoshio Ohara; Kazuhiko Ohrai; Kazufumi Yanagihara; Yukihiro Shigeta; Toru Tsukagoshi; Toru Yamashita

Collaboration


Dive into the Yoshio Ohara's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Tetsuya Kobayashi

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge